Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer

One of the globally common cancers is colorectal cancer (CRC). At present, a surgical approach remains a good option for CRC patients; however, 20% of surgically treated CRC patients experience metastasis. Currently, even the first-line used drug, oxaliplatin, remains inadequate for treating metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Misbah, Md, Kumar, Manoj, Lee, Kuen-Huar, Shen, Shing-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526582/
https://www.ncbi.nlm.nih.gov/pubmed/36193307
http://dx.doi.org/10.1155/2022/3825760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526582/
https://www.ncbi.nlm.nih.gov/pubmed/36193307
http://dx.doi.org/10.1155/2022/3825760

Ejemplares similares